English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT

Released

Journal Article

Scaffolding by ERK3 regulates MK5 in development.

MPS-Authors
/persons/resource/persons15961

Visel,  A.
Department of Genes and Behavior, MPI for biophysical chemistry, Max Planck Society;

External Resource
No external resources are shared
Fulltext (restricted access)
There are currently no full texts shared for your IP range.
Fulltext (public)

269137.pdf
(Publisher version), 0B

Supplementary Material (public)
There is no public supplementary material available
Citation

Schumacher, S., Laass, K., Kant, S., Shi, Y., Visel, A., Gruber, A. D., et al. (2004). Scaffolding by ERK3 regulates MK5 in development. EMBO Journal, 23(24), 4770-4779. Retrieved from http://www.nature.com/emboj/journal/v23/n24/full/7600467a.html.


Cite as: https://hdl.handle.net/11858/00-001M-0000-0012-EB86-E
Abstract
Extracellular-regulated kinase 3 (ERK3, MAPK6) is an atypical member of the ERKs, lacking the threonine and tyrosine residues in the activation loop, carrying a unique C-terminal extension and being mainly regulated by its own protein stability and/or by autophosphorylation. Here we show that ERK3 specifically interacts with the MAPK-activated protein kinase 5 (MK5 or PRAK) in vitro and in vivo. Expression of ERK3 in mammalian cells leads to nuclear-cytoplasmic translocation and activation of MK5 and to phosphorylation of both ERK3 and MK5. Remarkably, activation of MK5 is independent of ERK3 enzymatic activity, but depends on its own catalytic activity as well as on a region in the C-terminal extension of ERK3. In mouse embryonic development, mRNA expression patterns of ERK3 and MK5 suggest spatiotemporal coexpression of both kinases. Deletion of MK5 leads to strong reduction of ERK3 protein levels and embryonic lethality at about stage E11, where ERK3 expression in wild-type mice is maximum, indicating a role of this signalling module in development.